SA
Sign upLog In

Grace Therapeutics, Inc. (GRCE)

Operating Expenses

$25.69M

TTM · Period ending: · USD

GRCE logo

GRCE Operating Expenses

Latest reported$25.69M
GRCE TTM Operating Expenses ($1.28M → $25.69M)
High-resolution chart · PNG

GRCE operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Grace Therapeutics, Inc. Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
25,685,618
12,985,618
14,510,560
16,476,899
17,780,627
21,478,174
21,373,155
20,079,944
18,081,993
17,194,941
64,261,956
65,932,245
68,207,196
68,396,914
22,403,407
22,401,685
21,813,371
20,533,529
18,780,216
16,353,692
26,058,264
28,828,173
53,504,925
56,375,408
48,406,150
48,831,870
31,308,777
33,026,039
36,544,710
36,083,570
32,339,921
28,980,729
22,741,837
17,263,458
11,975,017
9,342,504
8,076,444
7,526,824
7,628,599
7,391,788
7,224,453
7,410,323
8,031,870
9,577,595
10,241,741
10,255,809
10,795,695
10,815,223
9,972,759
10,055,535
8,744,339
7,412,638
7,069,759
7,029,178
7,350,502
7,245,444
6,793,210
6,079,130
4,708,355
3,586,819
2,971,465
2,346,479
1,952,941
1,762,588
1,514,625
1,283,514
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.